Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer [NA]
This completed exploratory trial by Click Therapeutics evaluated attention biases in adults with multiple sclerosis, breast cancer, and lung…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Mapping the Longitudinal, Multidimensional Impact of MS in Relation to Variables Indicative of Neurological Reserve
A completed clinical trial evaluating how the long-term, multidimensional impact of multiple sclerosis relates to indicators of neurological…
-
FDA approval · 2024-05-10FDA Approved: MAVENCLAD — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for MAVENCLAD (cladribine) submitted by EMD Serono, Inc.
-
FDA label_change · 2024-05-09FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approved a Bayer supplemental application for Betaseron (interferon beta-1b), signaling changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis Patients [NA]
This clinical trial (NCT02747914) evaluating repetitive transcranial magnetic stimulation to reduce lower limb spasticity in multiple sclero…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating nabiximols Oromucosal Spray as add-on therapy for spasticity in people with Multiple Sclerosis has terminated with …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Wrist Position Sense in Individuals With Multiple Sclerosis
Clinical trial update indicating completion of a study examining wrist position sense in individuals with multiple sclerosis. The snippet do…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Olfactory and Trigeminal Functions in Patients With Multiple Sclerosis: Case-control Study
This clinical trial update describes a case-control study investigating olfactory and trigeminal functions in people with Multiple Sclerosis…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Auditory Functions in Patients With Multiple Sclerosis
A clinical trial is investigating auditory function in patients with Multiple Sclerosis and is currently recruiting. The study is sponsored …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Be Cool: An Innovative and Holistic Psychoeducational Program for Multiple Sclerosis Individuals
Clinical trial update indicates completion of a psychoeducational program for individuals with multiple sclerosis.
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis [Phase 1]
Phase 1 study evaluating autologous hematopoietic stem cell transplantation with fludarabine and cyclophosphamide conditioning in patients w…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
This document summarizes a tissue repository that provides annotated biospecimens for investigator-directed biomedical research, with ongoin…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Improving the Effect of Multiple Sclerosis Drugs by Chronobiology [NA]
A completed clinical trial evaluating whether chronobiology, i.e., drug timing, can improve the effectiveness of multiple sclerosis therapie…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Telerehabilitation in Multiple Sclerosis [NA]
A clinical trial registry entry indicates an active-not-recruiting study on telerehabilitation for individuals with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
Clinical trial update indicates that the GentleCath Men intermittent catheter with FeelClean technology has completed its study, evaluating …
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: The Reliability of the Nine Hole Peg Test in Patients With Multiple Sclerosis
This clinical trial update examines the reliability of the Nine Hole Peg Test as a measure of hand dexterity in individuals with multiple sc…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis [Phase 2]
Clinical trial update for IMU-838 evaluating efficacy, safety, and tolerability in progressive multiple sclerosis; Phase 2 study is currentl…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Awareness of Osteoporosis in Multiple Sclerosis Patients
A completed clinical trial assessed awareness of osteoporosis among individuals with multiple sclerosis.
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Effects of Balance Exercises Performed With Different Visual Stimuli [NA]
A clinical trial update describing a study on balance exercises using different visual stimuli for people with Multiple Sclerosis, with recr…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Running Title: Walking to Music and in Silence on a Treadmill [NA]
Clinical trial update for a multiple sclerosis study comparing walking to music versus walking in silence on a treadmill; the trial status i…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Evaluation of the Influence of a Core Muscle Control-Based Rehabilitation Program Patients With Multiple Sclerosis [NA]
This clinical trial update evaluates a core muscle control-based rehabilitation program for people with Multiple Sclerosis, including potent…
-
FDA approval · 2024-04-18FDA Approved: BACLOFEN — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approves a supplemental application for baclofen from Wilshire Pharmaceuticals, Inc., updating the existing baclofen product.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Natalizumab and Chronic Inflammation [Phase 4]
Phase 4 clinical trial update for natalizumab in chronic inflammation (multiple sclerosis) has been terminated with results posted in 2024.
-
FDA approval · 2024-04-16FDA Approved: FINGOLIMOD — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for fingolimod submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2024-04-15FDA Approved: FINGOLIMOD — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for fingolimod submitted by Dr. Reddy's Laboratories. This action approves changes associated with t…